SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ALECTINIB, COBIMETINIB, SATRALIZUMAB, VISMODEGIB, RISDIPLAM, OBINUTUZUMAB, EMICIZUMAB, TRASTUZUMAB SUBCUTÁNEO, TRASTUZUMAB EMTANSINA
1 supplier awarded•27 lots awarded•€28.35M awarded
Buyer: Servicio Murciano de Salud / Espinardo, Spain
Awarded value
€28.35M
Estimated value
€28.35M
Awarded at 100% of estimated value
Award date
Feb 12, 2024
Winners
1
Lots awarded
27
Award values
Notice total
€28.35M
Sum of lot awards
€55.47M
TED notice total and lot-level values do not exactly match.
Winners
Madrid, ESP
€28.1M This contract
32 award notices•78 awarded lots•€168.67M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0025 | Not specified | €15.6M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0022 | Not specified | €7.9M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0015 | ROCHE FARMA, S.A | €7.4M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | ROCHE FARMA, S.A | €4.4M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0026 | ROCHE FARMA, S.A | €3.0M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0023 | Not specified | €2.7M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | ROCHE FARMA, S.A | €2.5M | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0012 | ROCHE FARMA, S.A | €1.6M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0013 | ROCHE FARMA, S.A | €1.4M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | ROCHE FARMA, S.A | €1.3M | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0001 | ROCHE FARMA, S.A | €980,241 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | ROCHE FARMA, S.A | €915,270 | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0019 | Not specified | €884,112 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0018 | ROCHE FARMA, S.A | €833,464 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0010 | ROCHE FARMA, S.A | €732,220 | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0014 | ROCHE FARMA, S.A | €624,371 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | ROCHE FARMA, S.A | €606,492 | Other nervous system medicinal products (33661700) | |
| LOT-0006 | ROCHE FARMA, S.A | €436,464 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0002 | ROCHE FARMA, S.A | €331,782 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | ROCHE FARMA, S.A | €320,345 | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0020 | Not specified | €272,995 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | ROCHE FARMA, S.A | €259,000 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | ROCHE FARMA, S.A | €206,546 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0024 | Not specified | €118,477 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | ROCHE FARMA, S.A | €91,527 | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0021 | ROCHE FARMA, S.A | €52,499 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0027 | ROCHE FARMA, S.A | — | Antineoplastic and immunomodulating agents (33652000) |